RNWL
INTERNATIONAL REGISTRATION RENEWED
08/06/2026
Back to search
Official data from USPTO
BIOTRIAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIOTRIAL
ST13
US500000079036053Class
35, 42
Filing
79036053
Registration
3398765
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
08/06/2026
Trademark type
Word
Nice classes
35, 42
Filing date
08/08/2006
Registration date
03/18/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/17/2018
Last transaction
08/06/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
F-35000 RENNES, FR
Examiner
FATHY, DOMINIC
Law office
L80
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
BIOTRIAL
Representatives
Dana L.Tangren Dana L.Tangren
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Coordination of clinical trialscompilation of statistics and data management services for clinical trials
Class 42
Pharmaceutical product evaluation; medical research services in pharmacology; clinical pharmacology servicesconducting clinical trials; conducting clinical trials for medical research purposes; pharmaceutical research servicesmedicine interaction studies; pharmacological medical research; preclinical pharmacology medical research and studiesexperimental testing in pharmacology for the evaluation of synthetic or naturally-occurring moleculesin the field of cardiovascular pharmacologypharmacology of the central nervous systemrespiratory pharmacology and renal pharmacology; medical researchpharmaceutical research and parapharmaceutical research consultingtestingexaminations and medical researchin connection with pharmacodynamicsstudies in connection with the effects of medicines on primary physiological functionsthe central nervous systemcardiovasculargastrointestinal and liverrespiratoryrenalophthalmological functions; medicalpharmaceutical and parapharmaceutical medical research services in the field of pharmacology and carried out in the following therapeutic fieldsallergology and immunologycardiovascular systemcentral nervous systemdermatologyendocrinologymetabolismgastroenterologyhematologyrespiratory diseasesinfectious diseasesoncology; medical researchpharmaceutical research and parapharmaceutical research consultingtestingexaminations and medical researchin connection with pharmacokinetics; clinical medical research services in oncology; clinical medical research services in connection with anti-cancer medicines; data warehousing
Publications
History of USPTO decisions and trademark events.
32 publications found
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
03/17/2018
71AG
REGISTERED-SEC.71 ACCEPTED
03/17/2018
ES71
TEAS SECTION 71 RECEIVED
03/12/2018
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
03/18/2017
RNWL
INTERNATIONAL REGISTRATION RENEWED
09/01/2016
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
04/19/2014
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
04/19/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/19/2014
715F
REGISTERED - SEC. 71 & SEC. 15 FILED
03/17/2014
ES75
TEAS SECTION 71 & 15 RECEIVED
03/17/2014
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/22/2012
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/08/2008
FIMP
FINAL DISPOSITION PROCESSED
07/08/2008
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/18/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
03/18/2008
PUBO
PUBLISHED FOR OPPOSITION
01/01/2008
NPUB
NOTICE OF PUBLICATION
12/12/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/27/2007
ALIE
ASSIGNED TO LIE
11/27/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/22/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/29/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/28/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/28/2007
RFNT
REFUSAL PROCESSED BY IB
05/24/2007
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/04/2007
RFRR
REFUSAL PROCESSED BY MPU
05/04/2007
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/04/2007
CNRT
NON-FINAL ACTION WRITTEN
05/03/2007
DOCK
ASSIGNED TO EXAMINER
04/20/2007
NWAP
NEW APPLICATION ENTERED
04/20/2007
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/19/2007
Continuous trademark protection
Get notified about every new filing that threatens BIOTRIAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.